Prevention of the Angiographic Progression of Coronary and Vein-Graft Atherosclerosis by Gemfibrozil After Coronary Bypass Surgery in Men With Low Levels of HDL Cholesterol - LOCAT

Description:

This is a double-blind, randomized study of the effect of gemfibrozil on angiographic progression of atherosclerosis following coronary artery bypass surgery (CABG).